Since launching in 2018, hospital-owned Civica Rx works with about a third of the nation's hospitals and manufactures 80 drugs facing shortages, NBC affiliate KSL-TV reported Oct. 22. 

The FDA is reviewing a nasal spray that could be the first self-administered flu vaccine if approved.

As the U.S. anticipates an increase in knee and hip replacement surgeries, adding a second antibiotic does not help prevent postoperative infections and can even spur adverse events, according to a recent study.

Pharmacies are disappearing across the country as retail chains cull hundreds of locations, and the closures are disproportionately affecting vulnerable populations, The Washington Post reported Oct. 22.

The FDA granted full-approval to Pfizer's meningococcal disease immunization, Penbraya, on Oct. 20. 

Mark Cuban's Cost Plus Drug. Co. is teaming up with Birmingham (Ala.) Apothecary to offer Team Cuban Cards beginning Nov. 1, Bham Now reported Oct. 20. 

Roche has agreed to acquire Telavant Holdings — the maker of an inflammatory bowel disease drug — from Roivant Sciences and Pfizer for $7.25 billion, the Switzerland-based company said in an Oct. 23 news release. 

By the end of the year, THC products will be available for purchase in some Georgia pharmacies, CNN reported Oct. 20. 

Biotech companies and drugmakers are shelving their AI-designed therapeutics after a series of clinical setbacks, Endpoints News reported Oct. 19. 

For the first time, an experimental antiviral for dengue virus showed efficacy in humans, Johnson & Johnson said Oct. 20. 

Eli Lilly and Novo Nordisk are working to get weight-loss drugs approved for children as young as 6, Bloomberg reported Oct. 20.

CVS is voluntarily pulling from its shelves some common decongestants that contain an active ingredient FDA advisors have deemed ineffective at relieving congestion. 

Pharmacy leaders have already cracked the code of hospital C-suites, but increasingly, they're entering executive positions across health systems. 

A California health system has noted an "exponential" increase in patients using Wegovy, Mounjaro and other similar drugs for weight loss, according to a first-of-its-kind study.

Reata Pharmaceuticals — a rare disease drugmaker recently acquired by Biogen — filed a WARN notice Oct. 9, alerting Texas officials of its plans to cut 113 positions. The layoffs will take effect Nov. 27. 

Independent pharmacies and lawmakers are asking the federal government to probe UnitedHealth Group's proposed scoop of Amedisys, one of the largest home health and hospice care providers in the U.S.

Hospital groups and healthcare think tanks are urging CMS to revise its proposal to address medication shortages, which have been persistent for decades and have struck multiple therapeutic areas in 2023. 

Pfizer has set the list price for a five-day course of Paxlovid at $1,390, according to an exclusive report from The Wall Street Journal. 

UnitedHealth Group's pharmacy care business OptumRx has opened a location in Mesa, Ariz., according to an Oct. 17 news release. 

Amazon's pharmacy customers in College Station, Texas, can now receive their prescriptions via drone delivery in under an hour, the company announced Oct. 18.